Document is current
Any future updates will be listed below
-
Authors
Şahin, Edanur
Gündüz, Tuncay
Emekli, Ahmed Serkan
Ercanoğlu, Mazlum
Erden, Sevda Öztürk
Kürtüncü, Murat https://orcid.org/0000-0003-3286-2652
-
Funding
Funding for this research was provided by:
Gen-İlaç
Biogen
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 4 December 2024
First Online: 13 December 2024
Declarations
:
: This study was approved by the Clinical Research Ethics Committee of the Istanbul University, Istanbul Faculty of Medicine (E-29624016–050.99–1626160).
: Due to the retrospective design of the study, signed consent was not obtained from the participants.
: M.K. has received honoraria, travel support, and research funds from Merck, Novartis, Sanofi, Roche, Teva, Gen İlaç, Abdi İbrahim, and ARIS, and has served on advisory boards for these companies. T.G. has received honoraria and travel support from Merck, Novartis, Sanofi, Teva, Gen İlaç, Roche, Abdi İbrahim, and ARIS, and has served on advisory boards for these companies. M.E. is employed by Gen İlaç. A.S.E., E.Ş. and S.Ö.E. declare that they have no conflict of interest related to this study.
